Tff Pharmaceuticals,

TFF Pharmaceuticals, Inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology. Our patented Thin Film Freezing (TFF) platform makes it possible to turn more molecules into inhalable therapies. This novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tac-Lac Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.